Global Human Organs
完整報告名稱與涵蓋範圍
Global Human Organs-on-Chips Supply, Demand and Key Producers, 2026-2032
報告摘要
The global Human Organs-on-Chips market size is expected to reach $ 1452 million by 2032, rising at a market growth of 30.5% CAGR during the forecast period (2026-2032).
An Human Organs-on-Chip is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. Usually Human Organs-on-Chip mainly refers to organ chips.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumors), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.The industry's gross profit margin is approximately 40–50%.
Key market drivers include the following:
Demand for improved drug R&D efficiency drives technology adoption
"Organ-on-a-chip" technology is an in vitro research platform that integrates microfluidics, biomaterials, cell culture, and tissue engineering to simulate the structures, cellular interactions, and dynamic physiological environments of human organs within a miniature device. Traditional 2D cell models struggle to replicate the complex responses of human tissues, while animal experiments face limitations regarding species differences, costs, timelines, and ethical concerns. Pharmaceutical companies need to identify the toxicity, absorption, metabolism, and efficacy of drug candidates at an earlier stage to reduce the risk of clinical trial failure. Organ-on-a-chip systems can simulate blood flow, mechanical stretching, fluid shear stress, and multicellular co-culture environments, providing experimental conditions that more closely mimic the human body for studying organs such as the liver, lungs, intestines, kidneys, and heart, as well as the blood-brain barrier; consequently, they are increasingly being incorporated into drug screening and safety assessment workflows.
Precision medicine and disease modeling expand application boundaries
Biopharmaceutical R&D is shifting from standardized drug development toward targeted therapies, cell therapies, gene therapies, and personalized medicine, placing higher demands on the disease relevance of models and their ability to simulate patient-specific differences. Organ-on-a-chip platforms can utilize patient-derived cells, induced pluripotent stem cells (iPSCs), or tumor tissues to construct specific disease models, enabling the study of disease progression, drug sensitivity, and individual responses to treatment. Multi-organ-on-a-chip systems can also connect various tissue modules to simulate the processes of drug absorption, distribution, metabolism, and toxicity within the human body. As technologies related to cell sources, culture media, sensors, and imaging analysis mature, organ-on-a-chip technology will evolve from simple single-organ functional validation to the study of complex disease mechanisms and the evaluation of combination therapies.
The trend toward replacing animal testing and the establishment of standardization systems are accelerating commercialization.
The global life sciences industry continues to drive efforts to reduce, refine, and replace animal testing, with regulatory bodies, research institutions, and pharmaceutical companies increasingly accepting novel *in vitro* models. If organ-on-a-chip systems can yield stable, reproducible, and verifiable results, they hold the potential for use in specific drug toxicology tests, chemical safety assessments, and medical product research. Meanwhile, advancements in automated culture systems, standardized chip interfaces, real-time sensing, AI-driven image analysis, and high-throughput equipment are lowering operational barriers and enhancing experimental consistency. Future market growth will hinge on cross-laboratory validation, evaluation standards, regulatory approval, and scalable manufacturing capabilities; platforms that are compatible with existing laboratory equipment and feature comprehensive data analysis software and standard operating procedures are the most likely to achieve successful commercialization.
Report Scope
This report studies the global Human Organs-on-Chips demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Organs-on-Chips, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Organs-on-Chips that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Organs-on-Chips total market, 2021-2032, (USD Million)
Global Human Organs-on-Chips total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Human Organs-on-Chips total market, key domestic companies, and share, (USD Million)
Global Human Organs-on-Chips revenue by player, revenue and market share 2021-2026, (USD Million)
Global Human Organs-on-Chips total market by Type, CAGR, 2021-2032, (USD Million)
Global Human Organs-on-Chips total market by End User, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Human Organs-on-Chips market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, Micronit Microtechnologies B.V., Kirkstall, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Human Organs-on-Chips market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by End User. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Human Organs-on-Chips Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Human Organs-on-Chips Market, Segmentation by Type:
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Global Human Organs-on-Chips Market, Segmentation by Technology:
Cell Monolayer Chip
Scaffold or Hydrogel 3D Chip
Spheroid Chip
Other
Global Human Organs-on-Chips Market, Segmentation by Integration Level:
Single-Organ Chip
Multi-Tissue Organ Chip
Others
Global Human Organs-on-Chips Market, Segmentation by End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Companies Profiled:
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
AVATARGET
Suzhou Jiyan Biopharmaceutical
Key Questions Answered
1. How big is the global Human Organs-on-Chips market?
2. What is the demand of the global Human Organs-on-Chips market?
3. What is the year over year growth of the global Human Organs-on-Chips market?
4. What is the total value of the global Human Organs-on-Chips market?
5. Who are the Major Players in the global Human Organs-on-Chips market?
6. What are the growth factors driving the market demand?
授權報價
| Single User License | $4,480 USD |
| Multi User License | $6,720 USD |
| Corporate Users License | $8,960 USD |
目錄 Table of Contents
1 Supply Summary
1.1 Human Organs-on-Chips Introduction
1.2 World Human Organs-on-Chips Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Human Organs-on-Chips Total Market by Region (by Headquarter Location)
1.3.1 World Human Organs-on-Chips Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Human Organs-on-Chips Revenue (2021-2032)
1.3.3 China Based Company Human Organs-on-Chips Revenue (2021-2032)
1.3.4 Europe Based Company Human Organs-on-Chips Revenue (2021-2032)
1.3.5 Japan Based Company Human Organs-on-Chips Revenue (2021-2032)
1.3.6 South Korea Based Company Human Organs-on-Chips Revenue (2021-2032)
1.3.7 ASEAN Based Company Human Organs-on-Chips Revenue (2021-2032)
1.3.8 India Based Company Human Organs-on-Chips Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Organs-on-Chips Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 Demand Summary
2.1 World Human Organs-on-Chips Consumption Value (2021-2032)
2.2 World Human Organs-on-Chips Consumption Value by Region
2.2.1 World Human Organs-on-Chips Consumption Value by Region (2021-2026)
2.2.2 World Human Organs-on-Chips Consumption Value Forecast by Region (2027-2032)
2.3 United States Human Organs-on-Chips Consumption Value (2021-2032)
2.4 China Human Organs-on-Chips Consumption Value (2021-2032)
2.5 Europe Human Organs-on-Chips Consumption Value (2021-2032)
2.6 Japan Human Organs-on-Chips Consumption Value (2021-2032)
2.7 South Korea Human Organs-on-Chips Consumption Value (2021-2032)
2.8 ASEAN Human Organs-on-Chips Consumption Value (2021-2032)
2.9 India Human Organs-on-Chips Consumption Value (2021-2032)
3 World Human Organs-on-Chips Companies Competitive Analysis
3.1 World Human Organs-on-Chips Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Human Organs-on-Chips Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Human Organs-on-Chips in 2025
3.2.3 Global Concentration Ratios (CR8) for Human Organs-on-Chips in 2025
3.3 Human Organs-on-Chips Company Evaluation Quadrant
3.4 Human Organs-on-Chips Market: Overall Company Footprint Analysis
3.4.1 Human Organs-on-Chips Market: Region Footprint
3.4.2 Human Organs-on-Chips Market: Company Product Type Footprint
3.4.3 Human Organs-on-Chips Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Human Organs-on-Chips Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Human Organs-on-Chips Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Human Organs-on-Chips Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Human Organs-on-Chips Consumption Value Comparison
4.2.1 United States VS China: Human Organs-on-Chips Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Human Organs-on-Chips Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Human Organs-on-Chips Companies and Market Share, 2021-2026
4.3.1 United States Based Human Organs-on-Chips Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Human Organs-on-Chips Revenue, (2021-2026)
4.4 China Based Companies Human Organs-on-Chips Revenue and Market Share, 2021-2026
4.4.1 China Based Human Organs-on-Chips Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Human Organs-on-Chips Revenue, (2021-2026)
4.5 Rest of World Based Human Organs-on-Chips Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Human Organs-on-Chips Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Human Organs-on-Chips Revenue (2021-2026)
5 Market Analysis by Type
5.1 World Human Organs-on-Chips Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Brain-on-a-chip
5.2.2 Liver-on-a-chip
5.2.3 Kidney-on-a-chip
5.2.4 Lung-on-a-chip
5.2.5 Heart-on-a-chip
5.2.6 Intestine-on-a-chip
5.2.7 Vessel-on-a-chip
5.2.8 Other Organs
5.3 Market Segment by Type
5.3.1 World Human Organs-on-Chips Market Size by Type (2021-2026)
5.3.2 World Human Organs-on-Chips Market Size by Type (2027-2032)
5.3.3 World Human Organs-on-Chips Market Size Market Share by Type (2027-2032)
6 Market Analysis by Technology
6.1 World Human Organs-on-Chips Market Size Overview by Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology
6.2.1 Cell Monolayer Chip
6.2.2 Scaffold or Hydrogel 3D Chip
6.2.3 Spheroid Chip
6.2.4 Other
6.3 Market Segment by Technology
6.3.1 World Human Organs-on-Chips Market Size by Technology (2021-2026)
6.3.2 World Human Organs-on-Chips Market Size by Technology (2027-2032)
6.3.3 World Human Organs-on-Chips Market Size Market Share by Technology (2027-2032)
7 Market Analysis by Integration Level
7.1 World Human Organs-on-Chips Market Size Overview by Integration Level: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Integration Level
7.2.1 Single-Organ Chip
7.2.2 Multi-Tissue Organ Chip
7.2.3 Others
7.3 Market Segment by Integration Level
7.3.1 World Human Organs-on-Chips Market Size by Integration Level (2021-2026)
7.3.2 World Human Organs-on-Chips Market Size by Integration Level (2027-2032)
7.3.3 World Human Organs-on-Chips Market Size Market Share by Integration Level (2027-2032)
8 Market Analysis by End User
8.1 World Human Organs-on-Chips Market Size Overview by End User: 2021 VS 2025 VS 2032
8.2 Segment Introduction by End User
8.2.1 Pharmaceutical & Biotechnology Companies
8.2.2 Academic & Research Institutes
8.2.3 Cosmetics Industry
8.2.4 Others
8.3 Market Segment by End User
8.3.1 World Human Organs-on-Chips Market Size by End User (2021-2026)
8.3.2 World Human Organs-on-Chips Market Size by End User (2027-2032)
8.3.3 World Human Organs-on-Chips Market Size Market Share by End User (2021-2032)
9 Company Profiles
9.1 Emulate
9.1.1 Emulate Details
9.1.2 Emulate Major Business
9.1.3 Emulate Human Organs-on-Chips Product and Services
9.1.4 Emulate Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Emulate Recent Developments/Updates
9.1.6 Emulate Competitive Strengths & Weaknesses
9.2 Mimetas
9.2.1 Mimetas Details
9.2.2 Mimetas Major Business
9.2.3 Mimetas Human Organs-on-Chips Product and Services
9.2.4 Mimetas Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Mimetas Recent Developments/Updates
9.2.6 Mimetas Competitive Strengths & Weaknesses
9.3 TissUse
9.3.1 TissUse Details
9.3.2 TissUse Major Business
9.3.3 TissUse Human Organs-on-Chips Product and Services
9.3.4 TissUse Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TissUse Recent Developments/Updates
9.3.6 TissUse Competitive Strengths & Weaknesses
9.4 Valo Health
9.4.1 Valo Health Details
9.4.2 Valo Health Major Business
9.4.3 Valo Health Human Organs-on-Chips Product and Services
9.4.4 Valo Health Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Valo Health Recent Developments/Updates
9.4.6 Valo Health Competitive Strengths & Weaknesses
9.5 CN Bio Innovations
9.5.1 CN Bio Innovations Details
9.5.2 CN Bio Innovations Major Business
9.5.3 CN Bio Innovations Human Organs-on-Chips Product and Services
9.5.4 CN Bio Innovations Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CN Bio Innovations Recent Developments/Updates
9.5.6 CN Bio Innovations Competitive Strengths & Weaknesses
9.6 Hesperos
9.6.1 Hesperos Details
9.6.2 Hesperos Major Business
9.6.3 Hesperos Human Organs-on-Chips Product and Services
9.6.4 Hesperos Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Hesperos Recent Developments/Updates
9.6.6 Hesperos Competitive Strengths & Weaknesses
9.7 Draper Laboratory
9.7.1 Draper Laboratory Details
9.7.2 Draper Laboratory Major Business
9.7.3 Draper Laboratory Human Organs-on-Chips Product and Services
9.7.4 Draper Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Draper Laboratory Recent Developments/Updates
9.7.6 Draper Laboratory Competitive Strengths & Weaknesses
9.8 Nortis
9.8.1 Nortis Details
9.8.2 Nortis Major Business
9.8.3 Nortis Human Organs-on-Chips Product and Services
9.8.4 Nortis Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Nortis Recent Developments/Updates
9.8.6 Nortis Competitive Strengths & Weaknesses
9.9 Micronit Microtechnologies B.V.
9.9.1 Micronit Microtechnologies B.V. Details
9.9.2 Micronit Microtechnologies B.V. Major Business
9.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Services
9.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Micronit Microtechnologies B.V. Recent Developments/Updates
9.9.6 Micronit Microtechnologies B.V. Competitive Strengths & Weaknesses
9.10 Kirkstall
9.10.1 Kirkstall Details
9.10.2 Kirkstall Major Business
9.10.3 Kirkstall Human Organs-on-Chips Product and Services
9.10.4 Kirkstall Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Kirkstall Recent Developments/Updates
9.10.6 Kirkstall Competitive Strengths & Weaknesses
9.11 Cherry Biotech SAS
9.11.1 Cherry Biotech SAS Details
9.11.2 Cherry Biotech SAS Major Business
9.11.3 Cherry Biotech SAS Human Organs-on-Chips Product and Services
9.11.4 Cherry Biotech SAS Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cherry Biotech SAS Recent Developments/Updates
9.11.6 Cherry Biotech SAS Competitive Strengths & Weaknesses
9.12 Else Kooi Laboratory
9.12.1 Else Kooi Laboratory Details
9.12.2 Else Kooi Laboratory Major Business
9.12.3 Else Kooi Laboratory Human Organs-on-Chips Product and Services
9.12.4 Else Kooi Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Else Kooi Laboratory Recent Developments/Updates
9.12.6 Else Kooi Laboratory Competitive Strengths & Weaknesses
9.13 Altis Biosystems
9.13.1 Altis Biosystems Details
9.13.2 Altis Biosystems Major Business
9.13.3 Altis Biosystems Human Organs-on-Chips Product and Services
9.13.4 Altis Biosystems Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Altis Biosystems Recent Developments/Updates
9.13.6 Altis Biosystems Competitive Strengths & Weaknesses
9.14 Bi/ond
9.14.1 Bi/ond Details
9.14.2 Bi/ond Major Business
9.14.3 Bi/ond Human Organs-on-Chips Product and Services
9.14.4 Bi/ond Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Bi/ond Recent Developments/Updates
9.14.6 Bi/ond Competitive Strengths & Weaknesses
9.15 Netri
9.15.1 Netri Details
9.15.2 Netri Major Business
9.15.3 Netri Human Organs-on-Chips Product and Services
9.15.4 Netri Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Netri Recent Developments/Updates
9.15.6 Netri Competitive Strengths & Weaknesses
9.16 Xona Microfluidics
9.16.1 Xona Microfluidics Details
9.16.2 Xona Microfluidics Major Business
9.16.3 Xona Microfluidics Human Organs-on-Chips Product and Services
9.16.4 Xona Microfluidics Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Xona Microfluidics Recent Developments/Updates
9.16.6 Xona Microfluidics Competitive Strengths & Weaknesses
9.17 SynVivo
9.17.1 SynVivo Details
9.17.2 SynVivo Major Business
9.17.3 SynVivo Human Organs-on-Chips Product and Services
9.17.4 SynVivo Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 SynVivo Recent Developments/Updates
9.17.6 SynVivo Competitive Strengths & Weaknesses
9.18 Beijing Daxiang Biotech
9.18.1 Beijing Daxiang Biotech Details
9.18.2 Beijing Daxiang Biotech Major Business
9.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Product and Services
9.18.4 Beijing Daxiang Biotech Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Beijing Daxiang Biotech Recent Developments/Updates
9.18.6 Beijing Daxiang Biotech Competitive Strengths & Weaknesses
9.19 AVATARGET
9.19.1 AVATARGET Details
9.19.2 AVATARGET Major Business
9.19.3 AVATARGET Human Organs-on-Chips Product and Services
9.19.4 AVATARGET Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 AVATARGET Recent Developments/Updates
9.19.6 AVATARGET Competitive Strengths & Weaknesses
9.20 Suzhou Jiyan Biopharmaceutical
9.20.1 Suzhou Jiyan Biopharmaceutical Details
9.20.2 Suzhou Jiyan Biopharmaceutical Major Business
9.20.3 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product and Services
9.20.4 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Suzhou Jiyan Biopharmaceutical Recent Developments/Updates
9.20.6 Suzhou Jiyan Biopharmaceutical Competitive Strengths & Weaknesses
10 Industry Chain Analysis
10.1 Human Organs-on-Chips Industry Chain
10.2 Human Organs-on-Chips Upstream Analysis
10.3 Human Organs-on-Chips Midstream Analysis
10.4 Human Organs-on-Chips Downstream Analysis
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. World Human Organs-on-Chips Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Human Organs-on-Chips Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Human Organs-on-Chips Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Human Organs-on-Chips Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Human Organs-on-Chips Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Human Organs-on-Chips Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Human Organs-on-Chips Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Human Organs-on-Chips Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Human Organs-on-Chips Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Human Organs-on-Chips Players in 2025
Table 12. World Human Organs-on-Chips Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Human Organs-on-Chips Company Evaluation Quadrant
Table 14. Head Office of Key Human Organs-on-Chips Players
Table 15. Human Organs-on-Chips Market: Company Product Type Footprint
Table 16. Human Organs-on-Chips Market: Company Product Application Footprint
Table 17. Human Organs-on-Chips Mergers & Acquisitions Activity
Table 18. United States VS China Human Organs-on-Chips Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Human Organs-on-Chips Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Human Organs-on-Chips Companies, Headquarters (States, Country)
Table 21. United States Based Companies Human Organs-on-Chips Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Human Organs-on-Chips Revenue Market Share (2021-2026)
Table 23. China Based Human Organs-on-Chips Companies, Headquarters (Province, Country)
Table 24. China Based Companies Human Organs-on-Chips Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Human Organs-on-Chips Revenue Market Share (2021-2026)
Table 26. Rest of World Based Human Organs-on-Chips Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Human Organs-on-Chips Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Human Organs-on-Chips Revenue Market Share (2021-2026)
Table 29. World Human Organs-on-Chips Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Human Organs-on-Chips Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Human Organs-on-Chips Market Size by Type (2027-2032) & (USD Million)
Table 32. World Human Organs-on-Chips Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Human Organs-on-Chips Market Size Value by Technology (2021-2026) & (USD Million)
Table 34. World Human Organs-on-Chips Market Size by Technology (2027-2032) & (USD Million)
Table 35. World Human Organs-on-Chips Market Size by Integration Level, (USD Million), 2021 & 2025 & 2032
Table 36. World Human Organs-on-Chips Market Size Value by Integration Level (2021-2026) & (USD Million)
Table 37. World Human Organs-on-Chips Market Size by Integration Level (2027-2032) & (USD Million)
Table 38. World Human Organs-on-Chips Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 39. World Human Organs-on-Chips Market Size by End User (2021-2026) & (USD Million)
Table 40. World Human Organs-on-Chips Market Size by End User (2027-2032) & (USD Million)
Table 41. Emulate Basic Information, Manufacturing Base and Competitors
Table 42. Emulate Major Business
Table 43. Emulate Human Organs-on-Chips Product and Services
Table 44. Emulate Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Emulate Recent Developments/Updates
Table 46. Emulate Competitive Strengths & Weaknesses
Table 47. Mimetas Basic Information, Manufacturing Base and Competitors
Table 48. Mimetas Major Business
Table 49. Mimetas Human Organs-on-Chips Product and Services
Table 50. Mimetas Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Mimetas Recent Developments/Updates
Table 52. Mimetas Competitive Strengths & Weaknesses
Table 53. TissUse Basic Information, Manufacturing Base and Competitors
Table 54. TissUse Major Business
Table 55. TissUse Human Organs-on-Chips Product and Services
Table 56. TissUse Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TissUse Recent Developments/Updates
Table 58. TissUse Competitive Strengths & Weaknesses
Table 59. Valo Health Basic Information, Manufacturing Base and Competitors
Table 60. Valo Health Major Business
Table 61. Valo Health Human Organs-on-Chips Product and Services
Table 62. Valo Health Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Valo Health Recent Developments/Updates
Table 64. Valo Health Competitive Strengths & Weaknesses
Table 65. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 66. CN Bio Innovations Major Business
Table 67. CN Bio Innovations Human Organs-on-Chips Product and Services
Table 68. CN Bio Innovations Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CN Bio Innovations Recent Developments/Updates
Table 70. CN Bio Innovations Competitive Strengths & Weaknesses
Table 71. Hesperos Basic Information, Manufacturing Base and Competitors
Table 72. Hesperos Major Business
Table 73. Hesperos Human Organs-on-Chips Product and Services
Table 74. Hesperos Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Hesperos Recent Developments/Updates
Table 76. Hesperos Competitive Strengths & Weaknesses
Table 77. Draper Laboratory Basic Information, Manufacturing Base and Competitors
Table 78. Draper Laboratory Major Business
Table 79. Draper Laboratory Human Organs-on-Chips Product and Services
Table 80. Draper Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Draper Laboratory Recent Developments/Updates
Table 82. Draper Laboratory Competitive Strengths & Weaknesses
Table 83. Nortis Basic Information, Manufacturing Base and Competitors
Table 84. Nortis Major Business
Table 85. Nortis Human Organs-on-Chips Product and Services
Table 86. Nortis Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Nortis Recent Developments/Updates
Table 88. Nortis Competitive Strengths & Weaknesses
Table 89. Micronit Microtechnologies B.V. Basic Information, Manufacturing Base and Competitors
Table 90. Micronit Microtechnologies B.V. Major Business
Table 91. Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Services
Table 92. Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Micronit Microtechnologies B.V. Recent Developments/Updates
Table 94. Micronit Microtechnologies B.V. Competitive Strengths & Weaknesses
Table 95. Kirkstall Basic Information, Manufacturing Base and Competitors
Table 96. Kirkstall Major Business
Table 97. Kirkstall Human Organs-on-Chips Product and Services
Table 98. Kirkstall Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Kirkstall Recent Developments/Updates
Table 100. Kirkstall Competitive Strengths & Weaknesses
Table 101. Cherry Biotech SAS Basic Information, Manufacturing Base and Competitors
Table 102. Cherry Biotech SAS Major Business
Table 103. Cherry Biotech SAS Human Organs-on-Chips Product and Services
Table 104. Cherry Biotech SAS Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cherry Biotech SAS Recent Developments/Updates
Table 106. Cherry Biotech SAS Competitive Strengths & Weaknesses
Table 107. Else Kooi Laboratory Basic Information, Manufacturing Base and Competitors
Table 108. Else Kooi Laboratory Major Business
Table 109. Else Kooi Laboratory Human Organs-on-Chips Product and Services
Table 110. Else Kooi Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Else Kooi Laboratory Recent Developments/Updates
Table 112. Else Kooi Laboratory Competitive Strengths & Weaknesses
Table 113. Altis Biosystems Basic Information, Manufacturing Base and Competitors
Table 114. Altis Biosystems Major Business
Table 115. Altis Biosystems Human Organs-on-Chips Product and Services
Table 116. Altis Biosystems Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Altis Biosystems Recent Developments/Updates
Table 118. Altis Biosystems Competitive Strengths & Weaknesses
Table 119. Bi/ond Basic Information, Manufacturing Base and Competitors
Table 120. Bi/ond Major Business
Table 121. Bi/ond Human Organs-on-Chips Product and Services
Table 122. Bi/ond Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Bi/ond Recent Developments/Updates
Table 124. Bi/ond Competitive Strengths & Weaknesses
Table 125. Netri Basic Information, Manufacturing Base and Competitors
Table 126. Netri Major Business
Table 127. Netri Human Organs-on-Chips Product and Services
Table 128. Netri Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Netri Recent Developments/Updates
Table 130. Netri Competitive Strengths & Weaknesses
Table 131. Xona Microfluidics Basic Information, Manufacturing Base and Competitors
Table 132. Xona Microfluidics Major Business
Table 133. Xona Microfluidics Human Organs-on-Chips Product and Services
Table 134. Xona Microfluidics Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Xona Microfluidics Recent Developments/Updates
Table 136. Xona Microfluidics Competitive Strengths & Weaknesses
Table 137. SynVivo Basic Information, Manufacturing Base and Competitors
Table 138. SynVivo Major Business
Table 139. SynVivo Human Organs-on-Chips Product and Services
Table 140. SynVivo Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. SynVivo Recent Developments/Updates
Table 142. SynVivo Competitive Strengths & Weaknesses
Table 143. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
Table 144. Beijing Daxiang Biotech Major Business
Table 145. Beijing Daxiang Biotech Human Organs-on-Chips Product and Services
Table 146. Beijing Daxiang Biotech Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Beijing Daxiang Biotech Recent Developments/Updates
Table 148. Beijing Daxiang Biotech Competitive Strengths & Weaknesses
Table 149. AVATARGET Basic Information, Manufacturing Base and Competitors
Table 150. AVATARGET Major Business
Table 151. AVATARGET Human Organs-on-Chips Product and Services
Table 152. AVATARGET Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. AVATARGET Recent Developments/Updates
Table 154. AVATARGET Competitive Strengths & Weaknesses
Table 155. Suzhou Jiyan Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 156. Suzhou Jiyan Biopharmaceutical Major Business
Table 157. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product and Services
Table 158. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Suzhou Jiyan Biopharmaceutical Recent Developments/Updates
Table 160. Suzhou Jiyan Biopharmaceutical Competitive Strengths & Weaknesses
Table 161. Global Key Players of Human Organs-on-Chips Upstream (Raw Materials)
Table 162. Global Human Organs-on-Chips Typical Customers
List of Figures
Figure 1. Human Organs-on-Chips Picture
Figure 2. World Human Organs-on-Chips Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Human Organs-on-Chips Total Revenue (2021-2032) & (USD Million)
Figure 4. World Human Organs-on-Chips Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Human Organs-on-Chips Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Human Organs-on-Chips Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Human Organs-on-Chips Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Human Organs-on-Chips Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Human Organs-on-Chips Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Human Organs-on-Chips Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Human Organs-on-Chips Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Human Organs-on-Chips Revenue (2021-2032) & (USD Million)
Figure 13. Human Organs-on-Chips Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 16. World Human Organs-on-Chips Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 18. China Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 23. India Human Organs-on-Chips Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Human Organs-on-Chips by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Organs-on-Chips Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Organs-on-Chips Markets in 2025
Figure 27. United States VS China: Human Organs-on-Chips Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Human Organs-on-Chips Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Human Organs-on-Chips Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Human Organs-on-Chips Market Size Market Share by Type in 2025
Figure 31. Brain-on-a-chip
Figure 32. Liver-on-a-chip
Figure 33. Kidney-on-a-chip
Figure 34. Lung-on-a-chip
Figure 35. Heart-on-a-chip
Figure 36. Intestine-on-a-chip
Figure 37. Vessel-on-a-chip
Figure 38. Other Organs
Figure 39. Vessel-on-a-chip
Figure 40. World Human Organs-on-Chips Market Size Market Share by Type (2021-2032)
Figure 41. World Human Organs-on-Chips Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 42. World Human Organs-on-Chips Market Size Market Share by Technology in 2025
Figure 43. Cell Monolayer Chip
Figure 44. Scaffold or Hydrogel 3D Chip
Figure 45. Spheroid Chip
Figure 46. Other
Figure 47. World Human Organs-on-Chips Market Size Market Share by Technology (2021-2032)
Figure 48. World Human Organs-on-Chips Market Size by Integration Level, (USD Million), 2021 & 2025 & 2032
Figure 49. World Human Organs-on-Chips Market Size Market Share by Integration Level in 2025
Figure 50. Single-Organ Chip
Figure 51. Multi-Tissue Organ Chip
Figure 52. Others
Figure 53. World Human Organs-on-Chips Market Size Market Share by Integration Level (2021-2032)
Figure 54. World Human Organs-on-Chips Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 55. World Human Organs-on-Chips Market Size Market Share by End User in 2025
Figure 56. Pharmaceutical & Biotechnology Companies
Figure 57. Academic & Research Institutes
Figure 58. Cosmetics Industry
Figure 59. Others
Figure 60. World Human Organs-on-Chips Market Size Market Share by End User (2021-2032)
Figure 61. Human Organs-on-Chips Industrial Chain
Figure 62. Methodology
Figure 63. Research Process and Data Source
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Global Info Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們